Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-572-0 | CAS number: 827-52-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No experimental data are available for the toxicokinetic assessment of cyclohexylbenzene. A preliminary assessment of toxicokinetic behaviour is carried out based on the substance's physico-chemical properties. Absorption following oral administration will depend on whether micellular solubilisation occurs for cyclohexylbenzene. Dermal absorption is expected to be low due to the high lipophilicity of the substance. Absorption via the inhalation route is likely, but the risk of inhalation exposure is mitigated by the low vapour pressure of cyclohexylbenzene.
Key value for chemical safety assessment
Additional information
No studies are available that address the toxicokinetic behaviour of the test substance. Nevertheless, preliminary predictions of the extent to which a substance absorbs following uptake via the oral, dermal or inhalation route can be made from its physico-chemical properties.
Absorption
Oral absorption
Oral absorption can occur along the entire length of the gastro-intestinal tract. (Nielsen et al., 2010). The molecular weight of cyclohexylbenzene is less than 200, which favours the absorption process. Nevertheless, the substance’s high log Kow (5.6) indicates that passive diffusion through membranes might be hampered. In stead, absorption through micellular solubilisation might be relevant.
Dermal absorption
A number of physico-chemical factors determine the extent to which a substance may be absorbed by the dermal route.
Dermal absorption is likely for substance with the following properties (Nielsen et al., 2010):
· A vapour pressure below 100 Pa
· A Log Kow value between 1 and 4
· Water solubility:
- 1 - 100 mg/L = low to moderate absorption
- 100-10000 mg/L = high absorption
Cyclohexylbenzene has a vapour pressure of 25 Pa, a log Kow of 5.6 and a water solubility of 7 mg/L. Based on these physicochemical properties, the dermal absorption of the substance can be considered to be low. In order for a substance to be absorbed, it needs to penetrate through the stratum corneum to reach the epidermis. The relatively high lipophilicity of cyclohexylbenzene, as demonstrated by its high log Kow value, will enable the uptake into the stratum corneum. However, the rate of transfer between the stratum corneum and the epidermis will be slow and will limit absorption across the skin.
Inhalation absorption
The main physicochemical parameters determining the extent to which a liquid substance may be absorbed by the inhalation route are the vapour pressure, the log Kow and the water solubility (Nielsen et al., 2010).
Highly volatile substances are considered those substances that have a vapour pressure exceeding 25000 Pa, whereas a vapour pressure of less than 500 Pa indicates a low volatility.
Log Kow values above 0 indicate the potential absorption directly across the respiratory tract epithelium.
Very hydrophilic substances may be retained within the mucus or for low molecular weight substances (MW < 200), could be absorbed through aqueous pores. Very low water solubility (≤1 mg/L) indicates a potential for accumulation in the lung tissue.
Based on the physicochemical properties of cyclohexylbenzene (VP 25 Pa, log Kow 5.6 and WS 7 mg/L), it can be concluded that absorption of the substance through the respiratory tract epithelium is likely. However, based on the low vapour pressure it can be concluded that the substance has a low tendency to be evaporated, thus mitigating the likeliness of exposure via the inhalation route.
Metabolism and excretion
No information is available on the metabolism and excretion of cyclohexylbenzene.
References:
Nielsen, E., Ostergaard, G., Larsen, J.C. (2010). Toxicological Risk Assessment of Chemicals; A Practical Guide. Published by: Informa Healthcare. ISBN-13: 9780849372650.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.